{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:36:13Z","timestamp":1786527373762,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,8]],"date-time":"2027-08-08T00:00:00Z","timestamp":1817683200000},"content-version":"am","delay-in-days":403,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011071","name":"Fhi 360 Disaster Relief Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI050409"],"award-info":[{"award-number":["P30 AI050409"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM145735"],"award-info":[{"award-number":["T32 GM145735"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI186628"],"award-info":[{"award-number":["R21AI186628"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["7200AA20CA0016"],"award-info":[{"award-number":["7200AA20CA0016"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xphs.2026.104256","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:37:50Z","timestamp":1773941870000},"page":"104256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a melt-cast microneedle patch for sustained drug release of islatravir"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5109-4962","authenticated-orcid":false,"given":"Mikayla L.","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6993-2922","authenticated-orcid":false,"given":"Camryn P.","family":"Mekal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9843-6042","authenticated-orcid":false,"given":"Gulcin","family":"Arslan Azizoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-3614","authenticated-orcid":false,"given":"Raymond F.","family":"Schinazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9076-8448","authenticated-orcid":false,"given":"Mark R.","family":"Prausnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2026.104256_bib0001","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.xphs.2026.104256_bib0002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2011.38","article-title":"Patient medication adherence: measures in daily practice","volume":"26","author":"Jimmy","year":"2001","journal-title":"Oman Med J"},{"issue":"4","key":"10.1016\/j.xphs.2026.104256_bib0003","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/QAI.0000000000000993","article-title":"PrEP adherence patterns strongly affect individual HIV risk and observed efficacy in randomized clinical trials","volume":"72","author":"Dimitrov","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.xphs.2026.104256_bib0004","first-page":"138","article-title":"Maximizing the benefits of HIV preexposure prophylaxis","volume":"25","author":"Buchbinder","year":"2018","journal-title":"Top Antivir Med"},{"issue":"10","key":"10.1016\/j.xphs.2026.104256_bib0005","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/psp4.13212","article-title":"Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant","volume":"13","author":"Kim","year":"2024","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104256_bib0006","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/21642850.2020.1850288","article-title":"Adherence to the oral contraceptive pill: the roles of health literacy and knowledge","volume":"8","author":"Liddelow","year":"2020","journal-title":"Health Psychol Behav Med"},{"issue":"1","key":"10.1016\/j.xphs.2026.104256_bib0007","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11096-013-9861-1","article-title":"Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection","volume":"36","author":"Gengiah","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.xphs.2026.104256_bib0008","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","author":"Landovitz","year":"2021","journal-title":"N Engl J Med"},{"issue":"10485","key":"10.1016\/j.xphs.2026.104256_bib0009","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(25)00405-2","article-title":"Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study","volume":"405","author":"Jogiraju","year":"2025","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.xphs.2026.104256_bib0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.xphs.2026.104256_bib0011","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/COH.0000000000000467","article-title":"4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitor","volume":"13","author":"Markowitz","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"issue":"10","key":"10.1016\/j.xphs.2026.104256_bib0012","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41591-021-01479-3","article-title":"Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial","volume":"27","author":"Matthews","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.xphs.2026.104256_bib0013","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/S2352-3018(19)30372-8","volume":"7","author":"Schurmann","year":"2020","journal-title":"Lancet HIV"},{"issue":"21","key":"10.1016\/j.xphs.2026.104256_bib0014","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xphs.2026.104256_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","article-title":"Clinical translation of long-acting drug delivery formulations","volume":"7","author":"Li","year":"2022","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.xphs.2026.104256_bib0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-chembioeng-060816-101514","article-title":"Engineering microneedle patches for vaccination and drug delivery to skin","volume":"8","author":"Prausnitz","year":"2017","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"10.1016\/j.xphs.2026.104256_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/20417314221085390","article-title":"Application of microneedle patches for drug delivery; doorstep to novel therapies","volume":"13","author":"Nazary Abrbekoh","year":"2022","journal-title":"J Tissue Eng"},{"issue":"3","key":"10.1016\/j.xphs.2026.104256_bib0018","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12247-020-09460-2","article-title":"Microneedle array: applications, recent advances, and clinical pertinence in transdermal drug delivery","volume":"16","author":"Halder","year":"2021","journal-title":"J Pharm Innov"},{"issue":"3","key":"10.1016\/j.xphs.2026.104256_bib0019","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41551-018-0337-4","article-title":"Rapidly separable microneedle patch for the sustained release of a contraceptive","volume":"3","author":"Li","year":"2019","journal-title":"Nat Biomed Eng"},{"issue":"8","key":"10.1016\/j.xphs.2026.104256_bib0020","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1021\/acsabm.0c00671","article-title":"Silk fibroin microneedle patches for the sustained release of levonorgestrel","volume":"3","author":"Yavuz","year":"2020","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.xphs.2026.104256_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113919","article-title":"Microneedle-mediated vaccination: innovation and translation","volume":"179","author":"Sheng","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.xphs.2026.104256_bib0022","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1208\/s12249-022-02250-8","article-title":"Microneedle-based vaccine delivery: review of an emerging technology","volume":"23","author":"Mansoor","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"16","key":"10.1016\/j.xphs.2026.104256_bib0023","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1039\/D3BM00795B","article-title":"Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery","volume":"11","author":"Malek-Khatabi","year":"2023","journal-title":"Biomater Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104256_bib0024","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s13318-022-00793-6","article-title":"Evaluating islatravir administered via microneedle array patch for long-acting HIV Pre-exposure prophylaxis using physiologically based pharmacokinetic modelling","volume":"47","author":"Kinvig","year":"2022","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.xphs.2026.104256_bib0025","first-page":"652","article-title":"Incorporating surfactants into PCL microneedles for sustained release of a hydrophilic model drug","author":"NBaAA","year":"2024","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2026.104256_bib0026","doi-asserted-by":"crossref","first-page":"16616","DOI":"10.1021\/acsami.4c20010","article-title":"Schizophrenia treatment based on sustained release of risperidone from poly(lactic-co-glycolic) acid implantable microarray patch","volume":"17","author":"Li","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"10.1016\/j.xphs.2026.104256_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103114","article-title":"Systems level roadmap for solvent recovery and reuse in industries","volume":"24","author":"Aboagye","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xphs.2026.104256_bib0028","article-title":"Rapidly separable microneedle patches for controlled release of therapeutics for long-acting therapies","volume":"13","author":"Chenyuan Wang","year":"2022","journal-title":"Medicine in Drug Discov"},{"key":"10.1016\/j.xphs.2026.104256_bib0029","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jconrel.2021.08.012","article-title":"Immediate detachment of microneedles by interfacial fracture for sustained delivery of a contraceptive hormone in the skin","volume":"337","author":"Lee","year":"2021","journal-title":"J Control Rel"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104256_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larraneta","year":"2014","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104256_bib0031","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jbiomech.2003.12.010","article-title":"Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force","volume":"37","author":"Davis","year":"2004","journal-title":"J Biomech"},{"key":"10.1016\/j.xphs.2026.104256_bib0032","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s11095-016-1991-4","article-title":"Large size microneedle patch to deliver lidocaine through skin","volume":"33","author":"Kathuria","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104256_bib0033","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpb.2021.10.009","article-title":"Application of armodafinil-loaded microneedle patches against the negative influence induced by sleep deprivation","volume":"169","author":"Zhu","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2026.104256_bib0034","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.progpolymsci.2010.04.002","article-title":"The return of a forgotten polymer\u2014Polycaprolactone in the 21st century","volume":"35","author":"Woodruff","year":"2010","journal-title":"Progr Polym Sci"},{"key":"10.1016\/j.xphs.2026.104256_bib0035","first-page":"191","article-title":"The effect of temperature and pressure on polycaprolactone morphology","author":"Baptista","year":"2020","journal-title":"Polymer"},{"key":"10.1016\/j.xphs.2026.104256_bib0036","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jconrel.2023.05.049","article-title":"Control of drug release kinetics from hot-melt extruded drug-loaded polycaprolactone matrices","volume":"359","author":"Yun-Chu Chen","year":"2023","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2026.104256_bib0037","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2011.09.064","article-title":"Poly-\u0454-caprolactone based formulations for drug delivery and tissue engineering: a review","volume":"158","author":"Tapan","year":"2012","journal-title":"J Control Rel"},{"issue":"8","key":"10.1016\/j.xphs.2026.104256_bib0038","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1021\/acs.molpharmaceut.0c00316","article-title":"Islatravir case study for enhanced screening of thermodynamically stable crystalline anhydrate phases in pharmaceutical process development by hot melt extrusion","volume":"17","author":"Skomski","year":"2020","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104256_bib0039","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3109\/03639045.2013.809535","article-title":"Preformulation studies of EFdA, a novel nucleoside reverse transcriptase inhibitor for HIV prevention","volume":"40","author":"Zhang","year":"2014","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2026.104256_bib0040","series-title":"Elementary principles of chemical processes","author":"Felder","year":"2016"},{"key":"10.1016\/j.xphs.2026.104256_bib0041","article-title":"Microneedle created in skin in situ forming gels depot; an alternate approach to the sustained transdermal delivery of colchicine","volume":"101","author":"Abdur Rehman","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2026.104256_bib0042","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopha.2017.07.019","article-title":"Dissolving microneedles for transdermal drug delivery: advances and challenges","volume":"93","author":"Ita","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.xphs.2026.104256_bib0043","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2022.04.051","article-title":"Core-shell microneedle patch for six-month controlled-release contraceptive delivery","volume":"347","author":"Li","year":"2022","journal-title":"J Control Rel"},{"issue":"11","key":"10.1016\/j.xphs.2026.104256_bib0044","doi-asserted-by":"crossref","first-page":"eaaw8145","DOI":"10.1126\/sciadv.aaw8145","article-title":"Long-acting reversible contraception by effervescent microneedle patch","volume":"5","author":"Li","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.xphs.2026.104256_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125085","article-title":"Development of three-layer microneedle system for controlled and sustained release of Levonorgestrel: a pioneering approach to long-term contraceptive delivery","volume":"669","author":"Permana","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104256_bib0046","article-title":"Rapidly separable microneedle patch for the sustained release of a contraceptive","volume":"3","author":"RNT","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.xphs.2026.104256_bib0047","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jconrel.2022.03.057","article-title":"Non-oral routes, novel formulations and devices of contraceptives: an update","volume":"345","author":"Gupta","year":"2022","journal-title":"J Control Rel"},{"issue":"2","key":"10.1016\/j.xphs.2026.104256_bib0048","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.whi.2015.09.004","article-title":"Incorporating long-acting reversible contraception into primary care: a training and practice innovation","volume":"26","author":"Lydia","year":"2016","journal-title":"Women's Health Issues"},{"issue":"6","key":"10.1016\/j.xphs.2026.104256_bib0049","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.xphs.2020.02.009","article-title":"Intradermal implantable PLGA microneedles for etonogestrel sustained release","volume":"109","author":"He","year":"2020","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2026.104256_bib0050","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1021\/mp400359w","article-title":"Microneedle integrated transdermal patch for fast onset and sustained delivery of lidocaine","volume":"10","author":"Kochhar","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104256_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127988","article-title":"A universal powder-laden crosslinked chitosan microneedle patch for high-dose controllable drug delivery","volume":"255","author":"He","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104256_bib0052","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2018.03.031","article-title":"3D printed microneedles for insulin skin delivery","volume":"544","author":"Pere","year":"2018","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492600105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492600105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:00:45Z","timestamp":1786525245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492600105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S002235492600105X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104256","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a melt-cast microneedle patch for sustained drug release of islatravir","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104256"}}